secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001493152-26-003314
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma demonstrates AI tools for rare cancers at Jan 22 event
---------------------------------------------------------------------

- Event hosted on Jan 22, 2026 to showcase initial AI tools and multi-agentic system for rare cancers.
- Presentation furnished as Exhibit 99.1; no financial results or clinical data disclosed.
- Company discusses AI-driven drug development platform, but no specific milestones or partnerships announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226003314/0001493152-26-003314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226003314/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-003314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer